[
{":id":"row-e2ts-gjkj-a2te",":version":"rv-rzc2.kxcs-fmxv",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"1,189,122","status":"Issued","issue_date":"2020-10-30T00:00:00.000","country":"United States","patent_title":"Novel Formulations of Water-Insoluble Chemical Compounds and Methods of Using a Formulation of Compounds FL118 for Cancer Therapy","patent_assignee_owner":"Health Research, Inc."},
{":id":"row-hdaf-yuf3.a4pz",":version":"rv-9uzf-xpfy~6via",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"2,971,045","status":"Issued","issue_date":"2019-06-19T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Use of Recombinant T Cell Receptors for Direct Recognition of Tumor Antigen","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-y9ve_2grr.jcwf",":version":"rv-gwn5_vmux~bmv7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"3,183,342","status":"Issued","issue_date":"2021-05-21T00:00:00.000","country":"United States","patent_title":"Method for Prophylaxis and/or Treatment  of ErbB2 Positive Cancers","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-e7ah_kbfq-etp4",":version":"rv-kb3w_ctsx-r4g7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"3,325,095","status":"Issued","issue_date":"2022-03-30T00:00:00.000","country":"United States","patent_title":"System and Method for Administering Light Therapy to Curved and Large Surfaces","patent_assignee_owner":"Health Research, Inc."},
{":id":"row-qckf.p9d2-3nxc",":version":"rv-bbwk-nfdt-ad7h",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"4,446,122","status":"Issued","issue_date":"1984-05-01T00:00:00.000","country":"United States","patent_title":"Purified Human Prostate Antigen","patent_assignee_owner":"The Research Foundation for the State University of New York; Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3ces_qjqi.gs64",":version":"rv-mjyj~cim5~kbdm",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,198,460","status":"Issued","issue_date":"1993-03-20T00:00:00.000","country":"United States","patent_title":"Pyropheophorbides and Their Use in Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-pk7t.refm.rmks",":version":"rv-kuyw.tw43~znrz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,284,934","status":"Issued","issue_date":"1994-02-08T00:00:00.000","country":"United States","patent_title":"Synthesis and Utilization of Carbohydrate-Binding Polymer-Lectin Conjugates","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-z3eu~52f4.few4",":version":"rv-zdan-643h-7su8",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,314,905","status":"Issued","issue_date":"1994-05-24T00:00:00.000","country":"United States","patent_title":"Pyroheophorbides and Their Use in Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-723t-58id~27td",":version":"rv-dds3-67v6_tymc",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,433,946","status":"Issued","issue_date":"1995-07-18T00:00:00.000","country":"United States","patent_title":"Synthesis and Utilization of Therapeutic Agents for the Treatment of Lysosomal Storage Diseases","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ev45-y4q3~p2yk",":version":"rv-h4re_csm7.mucc",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,459,159","status":"Issued","issue_date":"1995-10-17T00:00:00.000","country":"United States","patent_title":"Pyropheophorbides and Their Use in Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nma2~6uqd_tk8m",":version":"rv-rqp2~nnek~ikk3",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,498,522","status":"Issued","issue_date":"1996-03-12T00:00:00.000","country":"United States","patent_title":"Methods for the Use of Spermidine/Spermine Niacetyltransferase as a Prognostic Indicator and/or a Tumor Response Marker","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-d4js~6bxw_7pv5",":version":"rv-x7pg-ztct.pqz9",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,498,710","status":"Issued","issue_date":"1996-03-12T00:00:00.000","country":"United States","patent_title":"Alkyl Ether Analogs of Benzoporphyrin Derivatives","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University of California"},
{":id":"row-q99u-q8dt.munx",":version":"rv-2iia~wyt4~h6qv",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,531,990","status":"Issued","issue_date":"1996-07-02T00:00:00.000","country":"United States","patent_title":"Method of Raising an Immune Response with an Anti-Idiotypic Having Correspondence with Human Hepatitis B","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University College London"},
{":id":"row-smyu~c97u~sqpj",":version":"rv-yfgt-guwy-vqaw",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,563,125","status":"Issued","issue_date":"1996-10-08T00:00:00.000","country":"United States","patent_title":"5'-DEOXY-5'-(SUBSTITUTED) Alkyl=Thioribose Compounds and Their Pharmaceutical Compositions","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and Pace University"},
{":id":"row-mvv5_nu7n_ep88",":version":"rv-r9a9.feyt.ywst",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,569,583","status":"Issued","issue_date":"1996-10-29T00:00:00.000","country":"United States","patent_title":"Rapid and Sensitive Detection of Cytomegalovirus","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-iud8_zwpf.2epw",":version":"rv-jg4m-qdri-xmmp",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,591,847","status":"Issued","issue_date":"1997-01-07T00:00:00.000","country":"United States","patent_title":"Long Wavelength Absorbing Photosensitizers Related to Purpurin-18, Bacteriopurpurin-18 and Related Compounds with Imide Linkages","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University of California"},
{":id":"row-yyg5.pvff-9ggw",":version":"rv-hacf~4b84-uvg5",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,620,864","status":"Issued","issue_date":"1997-04-15T00:00:00.000","country":"United States","patent_title":"Acceptor for Fucosyl transferase","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vq9z~2vcn~b3m9",":version":"rv-3zqq-ng2w.n56f",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,644,033","status":"Issued","issue_date":"1997-07-01T00:00:00.000","country":"United States","patent_title":"Monoclonal Antibodies that Define a Unique Antigen of Human B Cell Antigen of Human B Cell Antigen Receptor Complex and Methods of Using Same Diagnosis Treatment","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-7qar~rvsf.967m",":version":"rv-8gqz.vdma_vcxt",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,650,305","status":"Issued","issue_date":"1997-07-22T00:00:00.000","country":"United States","patent_title":"Method to Produce Hybrid Cells by Electrofusion","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jbnq-249i.9hev",":version":"rv-dr3z_nmrf_6hqh",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,652,105","status":"Issued","issue_date":"1997-07-29T00:00:00.000","country":"United States","patent_title":"Substrate for Detection of Mammalian 5-C DNA Methytransferase","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-xr75_8fmj_gnr9",":version":"rv-z5mi~ruyw.kir7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,669,253","status":"Issued","issue_date":"1997-09-16T00:00:00.000","country":"United States","patent_title":"Peptide Having Antigenic Properties Similar to a Determinant of Hepatitis B Surface Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University College London"},
{":id":"row-2bt8.9hd8_y89u",":version":"rv-8xys~gy2r-ietu",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,681,706","status":"Issued","issue_date":"1997-10-28T00:00:00.000","country":"United States","patent_title":"Mammalian Anoxia-Responsive Regulatory Element","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-wijb.zisg.5ykp",":version":"rv-eg2y~3kp4-bk9a",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,723,719","status":"Issued","issue_date":"1998-03-03T00:00:00.000","country":"United States","patent_title":"Transgenic Mouse as Model for Diases Involving Dopaminergic Dysfunction","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-85iu~q8p7_rmn3",":version":"rv-g8bk.qrjz-v8f3",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,744,135","status":"Issued","issue_date":"1998-04-28T00:00:00.000","country":"United States","patent_title":"Method of Raising an Immune Response with An Anti-Idiotypic Having Correspondence with Human Hepatitis B Surface Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University College London"},
{":id":"row-9vs9.vd6y-4fct",":version":"rv-av5f-neug~d8cc",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,789,213","status":"Issued","issue_date":"1998-08-04T00:00:00.000","country":"United States","patent_title":"Methods and Compositions for High Efficiency Loading, Transaction and Fusion of Cells by Electric Pulses","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-teyr-u2hg~tyzn",":version":"rv-2738_9sp2.i6dd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,846,706","status":"Issued","issue_date":"1998-12-18T00:00:00.000","country":"United States","patent_title":"Rapid  and Sensitive Detection of Herpes Simplex Virus","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-dmb8-h3na~4qq4",":version":"rv-a2sv_zba5-kt5k",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,856,087","status":"Issued","issue_date":"1999-01-05T00:00:00.000","country":"United States","patent_title":"Method for Detecting Immune Response to Hepatitis B","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University College London"},
{":id":"row-xpgk-2uj2-ph4g",":version":"rv-t4as~yk33_g7e7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,906, 918","status":"Issued","issue_date":"1999-05-25T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Measurement of Oxidative DNA","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-imuv_vdjq~2ah5",":version":"rv-4snb_xxx7_5bdv",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,912,147","status":"Issued","issue_date":"1999-06-15T00:00:00.000","country":"United States","patent_title":"A Rapid Means for Quantitating Genomic Instability","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-yv7c~xxy9_cbc4",":version":"rv-cydy_qf55.p69s",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,919,576","status":"Issued","issue_date":"1999-07-06T00:00:00.000","country":"United States","patent_title":"Immobilized Biological Membranes","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and US Department of Commerce"},
{":id":"row-cw3h.u8qi-zu87",":version":"rv-xtc5~k2wc_v3dy",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"5,928,641","status":"Issued","issue_date":"1999-07-27T00:00:00.000","country":"United States","patent_title":"Anti-Endoglin Monoclonal Antibodies and Their Use in Antiangiogenic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-47fd_tmn8_mcq2",":version":"rv-zzt3_adcu.a6pu",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,042,826","status":"Issued","issue_date":"2000-03-28T00:00:00.000","country":"United States","patent_title":"A Method for Inducing Apoptosis of Primary Central Nervous System B Cell Lymphomas","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3rhq~cyx8.cqpq",":version":"rv-ixvi_wmvn-3pdq",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,171,620","status":"Issued","issue_date":"2001-01-09T00:00:00.000","country":"United States","patent_title":"Method of Enhancing the Efficacy of Anti-Tumor Agents","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ajsb_kkw6-nn7e",":version":"rv-utc7-r39n_7rk6",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,187,588","status":"Issued","issue_date":"2001-02-13T00:00:00.000","country":"United States","patent_title":"Method for Increasing the Efficiency of Transfection","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jyd8-ew2b_67cg",":version":"rv-x4u7-fydt.7snu",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,190,660","status":"Issued","issue_date":"2001-02-20T00:00:00.000","country":"United States","patent_title":"Anti-Endoglin Monoclonal Antibodies and Their Use in Antiangiogenic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-v77i~qbiq~6uy6",":version":"rv-we6p_qxem~wwrd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,197,744","status":"Issued","issue_date":"2001-03-06T00:00:00.000","country":"United States","patent_title":"Tumor Necrosis Factor Inhibitory Protein Tip-B1 and Method of Using Same","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-zr8f~9tzr_v8et",":version":"rv-pmwu-s7ng.6kvf",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,200,566","status":"Issued","issue_date":"2001-03-13T00:00:00.000","country":"United States","patent_title":"Anti-Endoglin Monoclonal Antibodies and Their Use in Antiangiogenic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-238d-cpkr~xpa9",":version":"rv-8grx_frs8_diw2",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,319,501","status":"Issued","issue_date":"2001-11-20T00:00:00.000","country":"United States","patent_title":"Method of Immunizing Against Hepatitis B Virus","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and New York Blood Center"},
{":id":"row-gz4b.63xk~m39r",":version":"rv-jq26~i6bs~cwm9",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,413,775","status":"Issued","issue_date":"2002-07-02T00:00:00.000","country":"United States","patent_title":"Polyamine Analog-Activated SSAT Gene Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nvz3~544a~u2qv",":version":"rv-9ige_bsav_n8s4",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,426,094","status":"Issued","issue_date":"2002-07-30T00:00:00.000","country":"United States","patent_title":"Method of Enhancing the Efficacy of Anti-Tumor Agents","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vjv5_e85h.tw36",":version":"rv-87zy-btuw-y4hy",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,518,012","status":"Issued","issue_date":"2003-02-11T00:00:00.000","country":"United States","patent_title":"Method for Regulating MHC Antigens by Inhibitors of Histone Acetylation","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jmzw-rifd_hiwm",":version":"rv-xfvp~v9fg_zabd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,534,040","status":"Issued","issue_date":"2003-03-18T00:00:00.000","country":"United States","patent_title":"Chlorin and Bacteriochlorin-based Aminophenyl DTPA and N2S2 Conjugates for MR Contrast Media and Radiopharmaceuticals","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-m23i-7psz-bgua",":version":"rv-udkv.p3uh_vv4i",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,551,820","status":"Issued","issue_date":"2003-04-22T00:00:00.000","country":"United States","patent_title":"Expression of Immunogenic Hepatitis B Surface Antigens in Transgenic Plants","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-k3ge-ex9e~jre8",":version":"rv-rtn8_98qd_6eck",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,620,779","status":"Issued","issue_date":"2003-09-16T00:00:00.000","country":"United States","patent_title":"Method of Enhancing the Efficacy of Anti-Tumor Agents","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3c8c_m769.axzj",":version":"rv-j6t7~ygwz_yj3f",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,624,187","status":"Issued","issue_date":"2003-09-23T00:00:00.000","country":"United States","patent_title":"Long Wavelength Absorbing Bacteriochlorin Alkyl Ether Analogs","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-aije_i2u2~b9jq",":version":"rv-efjw.k2mn~2jck",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,939,893","status":"Issued","issue_date":"2005-09-06T00:00:00.000","country":"United States","patent_title":"Method of Reducing Toxicity of Anticancer Agents","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-hupc-edve.6byr",":version":"rv-89cp-2s7j.z2fe",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,939,948","status":"Issued","issue_date":"2005-09-06T00:00:00.000","country":"United States","patent_title":"GD2 Peptide Mimics","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center and Memorial Sloan Kettering"},
{":id":"row-dkxs_nahz~mame",":version":"rv-94yc-by8m~d7tr",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,965,009","status":"Issued","issue_date":"2005-11-15T00:00:00.000","country":"United States","patent_title":"P53 as Protein and Antibody Therefor","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-8umu_pm62_9sds",":version":"rv-qpsn-eaif-ktfk",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,977,271","status":"Issued","issue_date":"2005-12-20T00:00:00.000","country":"United States","patent_title":"A Method of Inhibition of Angiogenesis","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-eg9e_trd9~rbsw",":version":"rv-t4fg_xawj.dw6r",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,984,384","status":"Issued","issue_date":"2006-01-10T00:00:00.000","country":"United States","patent_title":"Stress Protein Compositions and Methods for Prevention and Treatment of Cancer and Infectious Disease","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-izgj_dum9.x3kd",":version":"rv-vxsc.vgqw.bgm5",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,991,805","status":"Issued","issue_date":"2006-01-31T00:00:00.000","country":"United States","patent_title":"Temperature Sensitive Control of Liposome-Cell Adhesion","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vat2.wp3c-tmm9",":version":"rv-aj85~sjvd.bsrp",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,964,778","status":"Issued","issue_date":"2005-11-15T00:00:00.000","country":"United States","patent_title":"Temperature Controlled Content Release from Liposomes","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-6vsh~dkn6-xats",":version":"rv-wx3e_w966~yxif",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"6,998,237","status":"Issued","issue_date":"2006-02-14T00:00:00.000","country":"United States","patent_title":"GD2 Peptide Mimics","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-qymy~cvg4-sw7x",":version":"rv-wyfa~mem5_mdct",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,053,210","status":"Issued","issue_date":"2006-05-30T00:00:00.000","country":"United States","patent_title":"Efficient Synthesis of Pyrophorphorbide-A and its Derivatives","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-j82b_wmda~g53t",":version":"rv-8fjk~77pd~b98m",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,078,014","status":"Issued","issue_date":"2006-07-18T00:00:00.000","country":"United States","patent_title":"Chlorin and Bacteriochlorin-based Aminophenyl DTPA and N2S2 Conjugates for MR Contrast Media and Radiopharmaceuticals","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-59eb_a5rt~85f7",":version":"rv-xe5j~eadx-fbdc",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,083,919","status":"Issued","issue_date":"2006-08-01T00:00:00.000","country":"United States","patent_title":"A Comprehensive High-Throughput Assay for Identification of Gene Expression Modifiers","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-fcnb_rycp~h27g",":version":"rv-jxuv~u8ie_8fkr",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,097,836","status":"Issued","issue_date":"2006-08-29T00:00:00.000","country":"United States","patent_title":"Method for Increasing the Efficacy of Anti-Tumor Agents by Anti-Endoglin Antibody","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-diuk_id4z-kczp",":version":"rv-7az4-uwrt-xzwe",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,098,195","status":"Issued","issue_date":"2006-08-29T00:00:00.000","country":"United States","patent_title":"Fluorinated Glucosamine Analogs Useful for Modulating Post-Translational Glycosylation of Cells","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and Brigham and Women's Hospital, Inc."},
{":id":"row-7p8k_jqze~rntj",":version":"rv-sbum-9s7z_vauz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,147,840","status":"Issued","issue_date":"2006-12-12T00:00:00.000","country":"United States","patent_title":"Oxo-Bacteriopyropheophorbide-A Carboxylic Acid and Esters Thereof","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ufpb.enks-shn3",":version":"rv-cemk.f4yu-quju",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,166,719","status":"Issued","issue_date":"2007-01-23T00:00:00.000","country":"United States","patent_title":"Fluorinated Photosensitizers Related to Chlorins and Bacteriochlorins for Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-cvqq~ir2x_azrr",":version":"rv-ab4u~fkyg-pcm5",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,282,203","status":"Issued","issue_date":"2007-10-16T00:00:00.000","country":"United States","patent_title":"Use of NOTCH Pathway Interfering Agents for Treatment of Plasma Cell Disorders","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-qa2m_hw9p-9n8v",":version":"rv-75up-jqhu-wb9d",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,306,801","status":"Issued","issue_date":"2007-12-11T00:00:00.000","country":"United States","patent_title":"Methods of Therapy for Cancers Characterized by Overexpression of the HER2 Receptor Protein","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center and University of Chicago"},
{":id":"row-5huc_2p4f-pvt5",":version":"rv-hwih~ppwj-yef7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,323,313","status":"Issued","issue_date":"2008-01-29T00:00:00.000","country":"United States","patent_title":"Improved Methods for Protein Interaction Determination","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-h48r_bw9t.qcvf",":version":"rv-y2mm_p8em_nwq2",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,348,153","status":"Issued","issue_date":"2008-03-25T00:00:00.000","country":"United States","patent_title":"Method for Identifying and Designing Immunogenic Peptides","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-fxbg.bbu9-8y9w",":version":"rv-7tr8-qptm.js9w",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,351,530","status":"Issued","issue_date":"2025-02-03T00:00:00.000","country":"United States","patent_title":"Prognostic Significance of Molecular Genetic Aberrations on Chromosome Segments 11p15.5 in Non-Small Cell Lung Cancer","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-k5eh~gscg_8j3t",":version":"rv-sb8u_kg3v_88ra",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,364,754","status":"Issued","issue_date":"2008-04-29T00:00:00.000","country":"United States","patent_title":"Ceramic Based Nanoparticles for Entrapping Therapeutic Agents for Photodynamic Therapy and Method of Using Same","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-4dxy.tyk2.5mpa",":version":"rv-revq-zqag_764r",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,378,096","status":"Issued","issue_date":"2008-05-27T00:00:00.000","country":"United States","patent_title":"Stress Protein Compositions and Methods for Prevention and Treatment of Cancer and Infectious Disease","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-m3wx_xhxi.8ecv",":version":"rv-jq52~x7di.78i9",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,425,414","status":"Issued","issue_date":"2008-09-16T00:00:00.000","country":"United States","patent_title":"Method of Prognosis of Metastasis by Detection of FRA12E Fragile Site within the SMRT Gene/Locus at Chromosome 12Q24","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-b2mm-hgrb~jhed",":version":"rv-7g8b_t448.shzi",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,744,854","status":"Issued","issue_date":"2010-06-29T00:00:00.000","country":"United States","patent_title":"Method Optimizing Cancer Therapy by Monitoring Maturation of Tumor Associated Vasculature by Selenium","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nqvm-2q2y_q89c",":version":"rv-v5jp~y2x4_fjjk",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,449,303","status":"Issued","issue_date":"2008-11-11T00:00:00.000","country":"United States","patent_title":"Use of JAG2 Expression in Diagnosis of Plasma Cell Disorders","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-eqxt.9jii-rjym",":version":"rv-yfj4~3xnq-sauz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,479,370","status":"Issued","issue_date":"2009-01-20T00:00:00.000","country":"United States","patent_title":"Detection of 13Q14 Chromosomal Alterations","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-9m3b.vyff~dzss",":version":"rv-xmup_navb.5j8v",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,501,509","status":"Issued","issue_date":"2009-03-10T00:00:00.000","country":"United States","patent_title":"Water Soluble Tetrapyrollic Photosensitizers for Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-x5dg.d9nn-9ua3",":version":"rv-863s.s9jj.ayt8",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,527,810","status":"Issued","issue_date":"2009-05-05T00:00:00.000","country":"United States","patent_title":"Oral Immunology Using Plant Product Containing Hepatitis Surface Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-w85h_3vfb.32n5",":version":"rv-m6u6~8r9n-t5sx",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,534,818","status":"Issued","issue_date":"2009-05-19T00:00:00.000","country":"United States","patent_title":"Method of Reducing Alopecia and Bladder Toxicity of Cyclophosphamide","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nds9.36nt_qdpc",":version":"rv-7vu4.htka~bstz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,569,221","status":"Issued","issue_date":"2009-08-04T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Identifying Agents that Alter Expression of Survivin","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-9gf2_38tx.6vvx",":version":"rv-qa8k~qi6k~vh9w",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,572,466","status":"Issued","issue_date":"2009-08-11T00:00:00.000","country":"United States","patent_title":"Oral Immunology Using Plant Product Containing A Non-Enteric Pathogen Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-bhue_yqgs-rzmq",":version":"rv-vwmh.ih9m-3buj",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,585,522","status":"Issued","issue_date":"2009-09-08T00:00:00.000","country":"United States","patent_title":"Oral Immunology Using Plant Product Containing A Non-Enteric Pathogen Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ssyz-fejq~hn4m",":version":"rv-u8fj.26vj.6aee",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,585,945","status":"Issued","issue_date":"2009-09-08T00:00:00.000","country":"United States","patent_title":"Use of Recombinant Heat Shock Protein Complexed to Kidney Cancer Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-6tuc~bht5-qmds",":version":"rv-iz3b_j72a~sbhk",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,592,421","status":"Issued","issue_date":"2009-09-22T00:00:00.000","country":"United States","patent_title":"HLA Class II Peptide Mimics","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-rpbw.s3hu_qqqa",":version":"rv-hpft~mcat-kwpd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,662,750","status":"Issued","issue_date":"2010-02-16T00:00:00.000","country":"United States","patent_title":"Protein-Protein Interaction Antagonist Screening Libraries Based Upon 1,4-Disubstituted Naphthalenes and Related Scaffolds","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-tsft~ytv4~ky5g",":version":"rv-bb5u~hy65~piip",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,687,473","status":"Issued","issue_date":"2010-03-30T00:00:00.000","country":"United States","patent_title":"5-amino-4-imidazolecarboxamide Riboside and its Nucleobase as Potentiators of Antifolate Transport and Metabolism","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-q2en.zqrx_dt96",":version":"rv-s2nc.cxwp~twi3",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,691,374","status":"Issued","issue_date":"2010-04-06T00:00:00.000","country":"United States","patent_title":"Method for Increasing the Efficacy of Anti-Tumor Agents by Anti-Endoglin Antibody","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-8xdp~ejbp.wdaf",":version":"rv-9bcj.hsz8_sdtn",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,820,664","status":"Issued","issue_date":"2010-10-26T00:00:00.000","country":"United States","patent_title":"Inhibitors of MEK","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vxuq~sryg_ii6a",":version":"rv-d6e5_28gh~p5bd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,820,143","status":"Issued","issue_date":"2010-10-26T00:00:00.000","country":"United States","patent_title":"Water Soluble Tetrapyrollic Photosensitizers for Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-q8i5-f9pq_9szz",":version":"rv-mkjq_qx22~w8j2",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,820,664","status":"Issued","issue_date":"2010-10-26T00:00:00.000","country":"United States","patent_title":"Inhibitors of MEK","patent_assignee_owner":"Bayer Pharma AG, Ardrea Biosciences, Inc."},
{":id":"row-f5am.98cd.qrqb",":version":"rv-ijb6-xz7t.7rtj",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,887,822","status":"Issued","issue_date":"2011-02-15T00:00:00.000","country":"United States","patent_title":"Peptides for Stimulating an Immune Response Against Melanoma","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-rqhq~e9za.acmg",":version":"rv-6hru~3ewv.u4x2",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,897,140","status":"Issued","issue_date":"2011-03-01T00:00:00.000","country":"United States","patent_title":"Multi DTPA Conjugated Tetrapyrollc Compounds for Phototherapeutic Contrast Agents","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-5ywb.dcpz_47dq",":version":"rv-xysp-84gv_kmrf",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,943,138","status":"Issued","issue_date":"2011-05-17T00:00:00.000","country":"United States","patent_title":"Survivin Peptides as Cancer Vaccines","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-xqhz_vjxx~z29v",":version":"rv-ttqf-x9k8_bs87",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,947,729","status":"Issued","issue_date":"2011-05-24T00:00:00.000","country":"United States","patent_title":"Adduct of Fluorescent Dye and Tumor Avid Tetrapyrrole","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-g7h5_uamk.frjr",":version":"rv-q6hr-gnzh~4eik",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,968,708","status":"Issued","issue_date":"2011-06-28T00:00:00.000","country":"United States","patent_title":"Azepans and Methods for Making and Using Same","patent_assignee_owner":"The Research Foundation for the State University of New York; Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-qb9t-xdri~vbc5",":version":"rv-xbzb_hyj5_ivne",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,976,846","status":"Issued","issue_date":"2011-07-12T00:00:00.000","country":"United States","patent_title":"Stress Protein Compositions and Methods for Prevention and Treatment of Cancer and Infectious Disease","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-um9c.fubz.y6e8",":version":"rv-wb9g~f22e_tgra",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,998,698","status":"Issued","issue_date":"2011-08-16T00:00:00.000","country":"United States","patent_title":"Method for Predicting Susceptibility to Radiaton Pneumonitis","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-gyt5-peqq-rzb3",":version":"rv-wzsu~zics~edrq",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,043,815","status":"Issued","issue_date":"2011-10-25T00:00:00.000","country":"United States","patent_title":"Methods for Analysis of PDEF and Survivin as Interconnected Cancer Biomarkers and Targets for Personalized Medicine","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-bas5-ksjz_36z3",":version":"rv-z7iz_c3yg_8gcn",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,048,640","status":"Issued","issue_date":"2011-11-01T00:00:00.000","country":"United States","patent_title":"Methods for Evaluating and Implementing Prostate Disease Treatments","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-fg6j.xpm9-7988",":version":"rv-swny~5k2y-6swz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,080,388","status":"Issued","issue_date":"2011-12-20T00:00:00.000","country":"United States","patent_title":"Stress Protein Compositions and Methods for Prevention and Treatment of Cancer and Infectious Disease","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-5d9n_cuv3_e5me",":version":"rv-auf2_6jkk-bt74",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,101,799","status":"Issued","issue_date":"2012-01-24T00:00:00.000","country":"United States","patent_title":"DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-q7fd.e2md-px3y",":version":"rv-ahvt.bdik-6fya",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,133,875","status":"Issued","issue_date":"2012-03-13T00:00:00.000","country":"United States","patent_title":"Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-w64b-dycv.77ts",":version":"rv-6z9p~p3yr~25kg",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,198,432","status":"Issued","issue_date":"2012-06-12T00:00:00.000","country":"United States","patent_title":"Porphyrin-Based Compounds for Tumor Imaging and Photodynamic Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-esv2.ygp5-a43q",":version":"rv-cd4c_csmc_pd4t",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,236,320","status":"Issued","issue_date":"2012-08-07T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Using CA9 Protein to Stimulate an Immune Response","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-dapd.p2sx.5ug5",":version":"rv-9724-uwtg~8rcp",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,241,845","status":"Issued","issue_date":"2012-08-14T00:00:00.000","country":"United States","patent_title":"Novel Steroid 5a-Reductase","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-6ec9-bvmn_zsmw",":version":"rv-n3nh.ba7i.ytg7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,278,072","status":"Issued","issue_date":"2012-10-02T00:00:00.000","country":"United States","patent_title":"Method for Synthesis of Diverse Sialylated Products Using Reversible Sialylation","patent_assignee_owner":"The Research Foundation for the State University of New York; Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-cije.c3q6~fbi2",":version":"rv-8agu-duf3~tc5q",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,314,076","status":"Issued","issue_date":"2012-11-20T00:00:00.000","country":"United States","patent_title":"Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-5u33-sqcb~uub8",":version":"rv-7jib-gmmr-xq7p",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,486,697","status":"Issued","issue_date":"2013-07-16T00:00:00.000","country":"United States","patent_title":"Inducing Cell Death by Inhibiting Adaptive Heat Shock Response","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-4m4j-inek.hkmx",":version":"rv-bzxt.fy86.3nz4",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,562,944","status":"Issued","issue_date":"2013-10-22T00:00:00.000","country":"United States","patent_title":"PAA Nanoparticles for Enhancement of Tumor Imaging","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-f26q~mwch-9eey",":version":"rv-5jf7.rmgp_7k5m",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,580,269","status":"Issued","issue_date":"2013-11-12T00:00:00.000","country":"United States","patent_title":"Survivin Peptides for Autoimmune Therapies","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nypv_6ta6_ifsa",":version":"rv-vxyi.fwce~dwq6",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,609,813","status":"Issued","issue_date":"2013-12-17T00:00:00.000","country":"United States","patent_title":"Prodrug Anti-Cancer Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ab83~7kfg_4fg6",":version":"rv-tnqs-a3vi.pqse",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,609,837","status":"Issued","issue_date":"2013-12-17T00:00:00.000","country":"United States","patent_title":"Metallation Enhancements in Tumor-Imaging and PDT Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-cmx4_wj6d.wz2w",":version":"rv-b4bs-uya4~2pin",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,679,459","status":"Issued","issue_date":"2014-03-25T00:00:00.000","country":"United States","patent_title":"B Ring Reduced-D Ring Oxidized Tetrapyrollic Photosensitizers for Photodynamic Therapy and Tumor Imaging","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3r6w_4yr5_ratz",":version":"rv-hb33~iawt_3n69",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,835,447","status":"Issued","issue_date":"2014-09-16T00:00:00.000","country":"United States","patent_title":"Method for Treating Androgen Receptor Positive Cancers","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center, Pancela Labs, Inc. and Cleveland BioLabs, Inc."},
{":id":"row-yay8-9rdh~rxu4",":version":"rv-ddfi~hvjw.puup",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"8,906,343","status":"Issued","issue_date":"2014-12-09T00:00:00.000","country":"United States","patent_title":"PAA Nanoplatforms Containing Fluorophores and Targeted Moieties Covalently Linked and Photosensitizer Post-Loaded","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ns5t-ufuk_9q7g",":version":"rv-ges5~q89r.6mrk",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,034,857","status":"Issued","issue_date":"2015-05-19T00:00:00.000","country":"United States","patent_title":"Methods for Reducing Superoxide Anions in Eukaryotic Organisms","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vhbm~ctjv_ijp6",":version":"rv-eufp~fr4v_p64s",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,044,140","status":"Issued","issue_date":"2015-06-02T00:00:00.000","country":"United States","patent_title":"Photodynamic Therapy with Spatially-Resolved Dual Spectroscopic Monitoring","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-yqq6.kk89_enut",":version":"rv-ifex-y24q.cn5s",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,050,291","status":"Issued","issue_date":"2015-06-09T00:00:00.000","country":"United States","patent_title":"Methods and Compositions Using Peroxiredoxin 1 (Prx1) as an Adjuvant","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-fvbz~wmut~3eug",":version":"rv-5f5d-ezif_eefm",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,155,791","status":"Issued","issue_date":"2015-10-13T00:00:00.000","country":"United States","patent_title":"Metallation Enhancements in Tumor-Imaging and PDT Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-sab3~yvyt.3xuk",":version":"rv-r5zm.ar3v~e8ej",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,205,095","status":"Issued","issue_date":"2015-12-08T00:00:00.000","country":"United States","patent_title":"Viral Vector Encoding a Toll-Like Receptor and Encoding a Toll-Like Receptor Agonist","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-gw28-s3mi_jb7s",":version":"rv-nahp~inrq_sjdz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,296,788","status":"Issued","issue_date":"2016-03-29T00:00:00.000","country":"United States","patent_title":"Prodrug Anti-Cancer Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-pnqp_hbd2.7i4m",":version":"rv-9kgx_5532~rktt",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,296,803","status":"Issued","issue_date":"2016-03-29T00:00:00.000","country":"United States","patent_title":"Methods and Compositions Containing FC Fusion Proteins for Enhancing Immune Responses","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-rqwk.25xq-cdid",":version":"rv-saaj~i8sz-tp95",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,315,582","status":"Issued","issue_date":"2016-04-19T00:00:00.000","country":"United States","patent_title":"Anti-Endoglin Antibodies and Knockin Mice Expressing Novel Human/Mouse Chimeric Endoglin","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ynsi~shdi_upwp",":version":"rv-it8q_i4f7.cc8c",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,387,213","status":"Issued","issue_date":"2016-07-12T00:00:00.000","country":"United States","patent_title":"Small Molecules Inhibiting Oncoprotein MYC","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-eapq-z85p~5z5t",":version":"rv-qzmq-523a_er5x",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,422,303","status":"Issued","issue_date":"2016-08-23T00:00:00.000","country":"United States","patent_title":"Formulations of Water-Insoluble Chemical Compounds and Methods of Using a Formulation of Compound FL118 for Cancer Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-t5sw-rpgf.wvxv",":version":"rv-rpds~tyjd_vnec",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,486,434","status":"Issued","issue_date":"2016-11-08T00:00:00.000","country":"United States","patent_title":"A Novel Method for Delivery and Use of Isothiocyanates for Prophylaxis and/or Therapy of Bladder Cancer","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-yfkc-eyc5~u5u8",":version":"rv-3v2k.r4nm~rynq",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,540,640","status":"Issued","issue_date":"2017-01-10T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Inhibiting Hypoxia Induced Damage","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-qizv.jj25.sfft",":version":"rv-b4ve~d95e_4hcz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,561,196","status":"Issued","issue_date":"2017-02-07T00:00:00.000","country":"United States","patent_title":"Methods for Evaluating and Implementing Prostate Disease Treatments","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-af2b_y2p9.6gm3",":version":"rv-rh9c.t7e9-j9b6",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,595,207","status":"Issued","issue_date":"2017-03-14T00:00:00.000","country":"United States","patent_title":"Method and System for Minimally-Invasive Surgery Training Using Tracking Data","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-j239-yfba-8c3d",":version":"rv-ckci.paex-yama",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,601,025","status":"Issued","issue_date":"2017-03-21T00:00:00.000","country":"United States","patent_title":"Method and System for Automatic Tool Position Determination for Minimally-Invasive Surgery Training","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jvwf-zm6f.ckj3",":version":"rv-4w5j_ppmh~wvix",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,751,825","status":"Issued","issue_date":"2017-09-05T00:00:00.000","country":"United States","patent_title":"TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-7euh.uner~mbx2",":version":"rv-c5bd-egbf_u7sr",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,822,154","status":"Issued","issue_date":"2017-11-21T00:00:00.000","country":"United States","patent_title":"Immune Modulator for Immunotherapy and Vaccine Formulation","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-e26j-taan_hgza",":version":"rv-b2ww-vdxg~e9b5",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"9,995,748","status":"Issued","issue_date":"2018-06-12T00:00:00.000","country":"United States","patent_title":"Biomarkers for Prostate Cancer Comprising Interleukin-8 (IL-8), Tumor Necrosis Factor Alpha and Soluble Tumor Necrosis Factor-Alpha Receptor 1","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3vct-n25m-jgt6",":version":"rv-6qb3_m9k6~x366",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,000,546","status":"Issued","issue_date":"2018-06-19T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Use of Recombinant T Cell Receptors for Direct Recognition of Tumor Antigen","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nxfp-yn4u-m79t",":version":"rv-cq4v~tdh7~aqqj",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,034,913","status":"Issued","issue_date":"2018-07-31T00:00:00.000","country":"United States","patent_title":"Anti-Angiogenic Peptides and Uses Thereof","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-7cdj_kcjs~aqyb",":version":"rv-m85z-mjtr_3q25",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,086,074","status":"Issued","issue_date":"2018-10-02T00:00:00.000","country":"United States","patent_title":"Compositions and Method for Light Triggered Release of Materials from Nanovesicles","patent_assignee_owner":"The Research Foundation for the State University of New York; Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jquq_afsq_pbyy",":version":"rv-uzk5_aptj.xfwd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,155,028","status":"Issued","issue_date":"2018-12-18T00:00:00.000","country":"United States","patent_title":"Method for Prophylaxis and/or Treatment of ERbB2 Positive Cancers","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-yv5x.3h89-8sh6",":version":"rv-kks4_y6cn-9gye",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,167,340","status":"Issued","issue_date":"2019-01-01T00:00:00.000","country":"United States","patent_title":"Anti-Survivin Antibodies for Cancer Therapy","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vdmg.ieh7_47mj",":version":"rv-ry6b.m7vm_3vd7",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,316,072","status":"Issued","issue_date":"2019-06-11T00:00:00.000","country":"United States","patent_title":"Immune Modulator for Immunotherapy and Vaccine Formulation","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-q79v-yxvw.v4nx",":version":"rv-jn4z_xr2c~bgwv",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,393,746","status":"Issued","issue_date":"2018-05-30T00:00:00.000","country":"United States","patent_title":"Biomarkers for Prostate Cancer","patent_assignee_owner":"Health Research, Inc, for Roswell Park Comprehensive Cancer Center"},
{":id":"row-5pvi-2cuj.kqrz",":version":"rv-ezpj-hsar_qbe8",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,487,362","status":"Issued","issue_date":"2019-11-26T00:00:00.000","country":"United States","patent_title":"A Novel Therapeutic Modality in Aggressive and CR CaP is Revealed by the snoRNA HBII-52","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-f8ue.3bkq~dqfa",":version":"rv-j9ek.5xtk~tdwz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,487,362 (B2)","status":"Issued","issue_date":"2019-11-26T00:00:00.000","country":"United States","patent_title":"Methods for Diagnosing Cancer Based on Small Nucleolar RNA HBII-52","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-h2ic~u96q_rdwu",":version":"rv-zunx.n8b7.5v76",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,478,477","status":"Issued","issue_date":"2019-10-15T00:00:00.000","country":"United States","patent_title":"Method for Prophylaxis and/or Treatment of ErbB1 Positive Cancers Using a Variant Peptidase D with Reduced Activity","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-bibn_bngi-uesf",":version":"rv-wr37.tv44-5vr4",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,478,477 (B)","status":"Issued","issue_date":"2019-11-19T00:00:00.000","country":"United States","patent_title":"Methods for Prophylaxis and/or Treatment of ErbB1 Positive Cancers","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-8cka.f8g9-wn3w",":version":"rv-y89r-ymdt~f8i6",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,624,881","status":"Issued","issue_date":"2018-04-11T00:00:00.000","country":"United States","patent_title":"Methods for Inducing Apoptosis in Cancer Cells","patent_assignee_owner":"Health Research, Inc., for Roswell Park Comprehensive Cancer Center"},
{":id":"row-6eex-3s2v~y6yr",":version":"rv-h45h-n47a.juvs",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"10,737,072","status":"Issued","issue_date":"2020-08-11T00:00:00.000","country":"United States","patent_title":"Central Catheters and Methods for Pulmonary Suffusion and Related Therapies.","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-nr3b.gru2~k93z",":version":"rv-2mzx-pfgr_75w9",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,007,182","status":"Issued","issue_date":"2021-05-18T00:00:00.000","country":"United States","patent_title":"Use of Atpenin to Activate Innate Immunity","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-9jvu~ys8y_mgci",":version":"rv-9pcs_riwq_f5gz",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,020,431","status":"Issued","issue_date":"2021-06-01T00:00:00.000","country":"United States","patent_title":"Compositions and Libraries Comprising Recombinant T-Cell Receptors and Methods of Using Recombinant T-Cell Receptors","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-qak2-eyc5~bu5k",":version":"rv-5w73_kp29-iwij",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"3,491,384","status":"Issued","issue_date":"2021-06-09T00:00:00.000","country":"Unitd States","patent_title":"Compositions and Methods for Rapid Cloning of T-Cell  Receptors","patent_assignee_owner":"Health Research, Inc."},
{":id":"row-erww~egpb~juxk",":version":"rv-y4gk.w6af-4b7y",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,040,217","status":"Issued","issue_date":"2021-06-22T00:00:00.000","country":"United States","patent_title":"System and Method for Delivering Light Dose to Tissue","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-37jm-szc4.59ih",":version":"rv-7uwz.abwm-hwy3",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,045,473","status":"Issued","issue_date":"2017-11-17T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Therapy of Prostate Cancer Using Drug  Combinations to Target Polyamine Biosynthesis","patent_assignee_owner":"Health Research, Inc. for Roswell Parl Comprehensive Cancer Center"},
{":id":"row-rwwn~z8f9.k34d",":version":"rv-67tr.63by.eu7e",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"13,566,411","status":"Issued","issue_date":"2020-02-25T00:00:00.000","country":"United States","patent_title":"Multifunctional Nanoplatforms for Fluorescence Imaging and Photodynamic Therapy Developed by Post Loading Photosensitizer and Fluorophorie to Polyacrylamide Nanoparticles","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-iteq_6d79~ndia",":version":"rv-y6ja.qdrn.rgpc",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,051,901","status":"Issued","issue_date":"2021-07-06T00:00:00.000","country":"United States","patent_title":"Medical Instrument Cart    (Smart Cart)","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-aerk.ms3w.snaq",":version":"rv-wf88~envq~gjy4",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,071,684","status":"Issued","issue_date":"2021-07-27T00:00:00.000","country":"United States","patent_title":"Abdominal Shaking Device","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-jauk~p5s8.rnq9",":version":"rv-v2aj-hynp-5irx",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,083,793","status":"Issued","issue_date":"2021-08-10T00:00:00.000","country":"United States","patent_title":"Epidermal Growth Factor Receptor (EGFR)","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-h78a.qx33~bxhj",":version":"rv-9qsc~i9cx_fyta",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,103,563","status":"Issued","issue_date":"2021-08-31T00:00:00.000","country":"United States","patent_title":"Medical for Prophylaxis and/or Treatment of ErbB2 Positive Cancers","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-ddci-nac9~zgkt",":version":"rv-iqc5-wzcr_i7h8",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,155,595","status":"Issued","issue_date":"2021-10-26T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Use of Recombinant T Cell Receptors for Direct Recognition of Tumor Antigen","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-k635.a6qq~n6tj",":version":"rv-h4xj_abzg~ac7c",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,167,151","status":"Issued","issue_date":"2021-11-09T00:00:00.000","country":"United States","patent_title":"Medical and System for Transferring Radiation Therapy","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-fx3m_hqti-99vd",":version":"rv-xipv~qq2j_5yjd",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,254,914","status":"Issued","issue_date":"2022-02-22T00:00:00.000","country":"United States","patent_title":"Enrichment of CD16+ Monocytes to Improve Dendritic Cell Vaccine Quality","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-dtih_f526_dgqq",":version":"rv-j5c4_vmgx.je39",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,344,742","status":"Issued","issue_date":"2022-05-31T00:00:00.000","country":"United States","patent_title":"System and Method for Administering Light Therapy to Curved and Large Surfaces","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-cmnx.qrvj~igsk",":version":"rv-59u4~hicj~zyza",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,467,152","status":"Issued","issue_date":"2022-10-11T00:00:00.000","country":"United States","patent_title":"Circulating Survivin-Positive Exosomes","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-89us-8qch~kgzi",":version":"rv-g58s~k7w7.xbnj",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"40001734B","status":"Issued","issue_date":"2023-02-10T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Rapid Cloning of T-Cell  Receptors","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-vz9p.4mqe_xnae",":version":"rv-g48z.uka4~9ivs",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"7,384,896","status":"Issued","issue_date":"2023-07-22T00:00:00.000","country":"United States","patent_title":"Major Histocompatibility Complex (MHC) Class-II Expressing Cancer Cell Vaccine and Methods of Use for Producing Integrated Immune Responses","patent_assignee_owner":"Health Research, Inc. for Roswell Park Comprehensive Cancer Center"},
{":id":"row-3wqd.tky4~f76r",":version":"rv-tvam.5dbu.5wy2",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"11,773,181 B2","status":"Issued","issue_date":"2023-10-03T00:00:00.000","country":"United States","patent_title":"Anti-Survivin Antibodies for Cancer Therapy","patent_assignee_owner":"Health Research, Inc."},
{":id":"row-8udi.yzcd~5nxn",":version":"rv-32ir-hkav~j6ux",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"12,125,206","status":"Issued","issue_date":"2024-10-22T00:00:00.000","country":"United States","patent_title":"In Vivo Magnetic Resonance Image Distortion Check Aparatus Method","patent_assignee_owner":"Health Research, Inc."},
{":id":"row-zecm~v9p8.uggt",":version":"rv-y67x-v6hk_dci4",":created_at":"2025-09-26T18:36:09.348Z",":updated_at":"2025-09-26T18:36:09.348Z","patent_number":"16,318,787","status":"Issued","issue_date":"2025-03-28T00:00:00.000","country":"United States","patent_title":"Compositions and Methods for Rapid Cloning of T-Cell  Receptors","patent_assignee_owner":"Health Research, Inc."}
]
